One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: The significance of imidazole resistance

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 2, 1997, Pages 305-309

  Thijs, J C ^a   Van Zwet, A A ^b   Thijs, W J ^a   Van Der Wouden, E J ^a   Kooy, A ^a  

^a Bethesda Hospital   (Netherlands)

^b Public Health Service of Groningen   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; IMIDAZOLE DERIVATIVE; OMEPRAZOLE; TINIDAZOLE;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BREATH ANALYSIS; DRUG EFFICACY; DRUG RESISTANCE; DYSPEPSIA; ENDOSCOPY; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL;

EID: 0030972411     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.155329000.x     Document Type: Article

References (30)

1. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-9.
2. Thijs JC, Kuipers EJ, Van Zwet AA, Pena AS, De Graaff J. Treatment of Helicobacter pylori infections. Q J Med 1995; 88: 369-89.
3. De Boer WA, Tytgat GNJ. 90% Cure; which anti-Helicobacter therapy can achieve this goal? Am J Gastroenterol 1995; 90: 1381-2 (Editorial).
4. Graham DY. A reliable cure for H. pylori infection? Gut 1995; 37: 154-6.
5. Graham DY, Lew GM, Malaty HM. et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493-6.
6. Bazzoli F, Zagary RM, Fossi S, et al. Short term, low dose triple therapy for eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6: 773-7.
7. Jaup BH, Norrby A. Low dose, short term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am J Gastroenterol 1995; 90: 943-5.
8. Labenz J, Stolte M, Ruhl GH, et al. One week low dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7: 9-11.
9. Lind T, Veldhuizen van Zanten S, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH 1 study. Helicobacter 1996; 1: 138-44.
10. Jaup BH, Norrby A. Comparison of two low dose one-week triple therapy regimens with and without metronidazole for cure of H. pylori infection. Aliment Pharmacol Ther 1996; 10: 275-7.
11. Dalla Libera M, Pazzi P, Carli G, et al. High effectiveness and safety of one-week antibiotic regimen in Helicobacter pylori eradication. Aliment Pharmacol Ther 1996; 10: 203-6.
12. Moayyedi P, Sahay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7: 835-40.
13. Xia HX, Buckley M, Hyde D, Keane CT, O'Morain CA. Effects of antibiotic-resistance on clarithromycin-combined triple therapy for Helicobacter pylori. Gut 1995; 37(Suppl. 1): A55(Abstract).
14. Bell GD, Powell KU, Burridge SM, et al. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9: 41-6.
15. Hudson N, Brydon WG, Eastwood MA, et al. Successful Helicobacter pylori eradication incorporating a one week regimen. Aliment Pharmacol Ther 1995; 9: 47-50.
16. Reilly TG, Poxon V, Walt RP. The eradication of Helicobacter pylori in practice: an audit of three years clinical experience with peptic ulcer patients. Gut 1995; 37(Suppl. 1): A87(Abstract).
17. Labenz J, Stolte M, Peitz U, et al. One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 10: 207-10.
18. Arvind AS, Cook RS, Tabaqchali S, Farthing MJG. One-minute endoscopy room test for Campylobacter pylori. Lancet 1988; i: 704.
19. Van Zwet AA, Thijs JC, Roosendaal R, et al. Review: Practical diagnosis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1996; 8: 501-7.
20. De Boer WA, Thijs JC, Borody TJ, et al. Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens. Eur J Gastroenterol Hepatol 1996; 8: 641-4.
21. Van Zwet AA, Thijs JC, Kooistra-Smid AMD, Schirm J, Snijder JAM. Sensitivity of culture compared with that of polymerase chain reaction for detection of Helicobacter pylori from antral biopsy samples. J Clin Microbiol 1993; 31: 1918-20.
22. 13C-urea breath test for the detection of Helicobacter pylori. Evaluation of the test performed clinically and at home. Eur J Gastroenterol Hepatol 1995; 7: 603-7.
23. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrofic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996; 334: 1018-22.
24. Mannes GA, Bayerdörffer E, Hele C, et al. An increasing dose of omeprazole combined with amoxicillin increases the eradication rate of Helicobacter pylori. Gastroenterology 1993; 104: A140(Abstract).
25. Labenz J, Gyenes E, Rühl GH, Börsch G. Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol 1993; 88: 491-5.
26. Glupczynski Y, Burette A, De Koster E, et al. Metronidazole resistance in Helicobacter pylori. Lancet 1990; 335: 976-7.
27. Rautelin H, Seppälä K, Renkonen OV, Vainio U, Kosunen TU. Metronidazole resistance in the therapy of Helicobacter pylori infection. Antimicrob Agents Chemother 1992; 36: 163-6.
28. Van Zwet AA, Thijs JC, Oom JAJ, Hoogeveen J, Düringshoff BL. Failure to eradicate Helicobacter pylori in patients with metronidazole resistant strains. Eur J Gastroenterol Hepatol 1993; 5: 185-6.
29. Thijs JC, Van Zwet AA, Oey HB. Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol 1993; 28: 934-8.
30. Thijs JC, Van Zwet AA, Moolenaar W, Wolfhagen MJHM, Ten Bokkel Huinink T. Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection : a multicenter, prospective, randomised, controlled study of efficacy and side effects. Am J Gastroenterol 1996; 91: 93-7.